Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit

Clinical cancer research : an official journal of the American Association for Cancer Research

Volumn 20, Issue 17, 2014, Pages 4488-4498

  Koeppen, Hartmut ^a   Yu, Wei ^a   Zha, Jiping ^a   Pandita, Ajay ^a   Penuel, Elicia ^a   Rangell, Linda ^a   Raja, Rajiv ^a   Mohan, Sankar ^a   Patel, Rajesh ^a   Desai, Rupal ^a   Fu, Ling ^a   Do, An ^a   Parab, Vaishali ^a   Xia, Xiaoling ^a   Januario, Tom ^a   Louie, Sharianne G ^a   Filvaroff, Ellen ^a   Shames, David S ^a   Wistuba, Ignacio ^a   Lipkind, Marina ^a   Huang, Jenny ^a   Lazarov, Mirella ^a   Ramakrishnan, Vanitha ^a   Amler, Lukas ^a   Phan, See Chun ^a   Patel, Premal ^a   Peterson, Amy ^a   Yauch, Robert L ^a   more..

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; MESSENGER RNA; MET PROTEIN, HUMAN; MONOCLONAL ANTIBODY; ONARTUZUMAB; QUINAZOLINE DERIVATIVE; SCATTER FACTOR RECEPTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BIOSYNTHESIS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFECTS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; ERLOTINIB HYDROCHLORIDE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-MET; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER;

EID: 84905011727     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1836     Document Type: Article

References (0)